Intelligent Extracorporeal Blood Treatment Systems
Legal Citation
Summary of the Inventive Concept
The present invention integrates AI, IoT, blockchain, and nanomaterials with extracorporeal blood treatment devices to create a more efficient, patient-centric, and data-driven system.
Background and Problem Solved
The original patent disclosed an extracorporeal blood treatment apparatus with a blood-warming device. However, it lacked advanced data management, real-time monitoring, and adaptive control capabilities. The new inventive concept addresses these limitations by incorporating synergistic technologies to enhance patient safety, treatment efficacy, and data integrity.
Detailed Description of the Inventive Concept
The inventive concept comprises an extracorporeal blood treatment device, a blood warmer, and an extracorporeal blood circuit. Additionally, it integrates a blockchain-based data management system for secure and transparent treatment data tracking, an IoT-enabled sensor for real-time monitoring of priming parameters, and an AI-powered control system for optimizing treatment parameters based on patient data. Furthermore, a nanomaterial-based coating can be applied to reduce blood clotting and improve biocompatibility. The system enables personalized treatment, predictive maintenance, and remote monitoring, improving overall treatment outcomes.
Novelty and Inventive Step
The new claims introduce the innovative combination of AI, IoT, blockchain, and nanomaterials with extracorporeal blood treatment devices, providing a synergistic system that enhances patient safety, treatment efficacy, and data integrity. This integration is non-obvious and novel compared to the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different AI algorithms, IoT protocols, or blockchain platforms. Variations may involve integrating additional sensors, actuators, or data analytics tools to further enhance the system's capabilities.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of extracorporeal blood treatment, patient monitoring, and personalized medicine. The target market includes hospitals, clinics, and medical research institutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M1/369 |
| A | A61 | A61M1/3623 |
| A | A61 | A61M1/3626 |
| A | A61 | A61M1/3627 |
| A | A61 | A61M1/3643 |
| A | A61 | A61M39/28 |
| A | A61 | A61M2205/3344 |
| A | A61 | A61M2205/36 |
Original Patent Information
| Patent Number | US 11,857,715 |
|---|---|
| Title | Extracorporeal blood treatment apparatus |
| Assignee(s) | Gambro Lundia AB |